Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-050917
Filing Date
2013-09-27
Accepted
2013-09-27 18:11:42
Documents
1
Period of Report
2013-09-25

Document Format Files

Seq Description Document Type Size
1 10B5-1 PLAN EXERCISE AND SALE rrd391386.html 4  
1 10B5-1 PLAN EXERCISE AND SALE rrd391386.xml 4 6925
  Complete submission text file 0001181431-13-050917.txt   8511
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Markvicka Taunia (Reporting) CIK: 0001545282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 131121001